Zealand Pharma at Cantor Global Healthcare Conference in September 2024

On September 13, 2024, Zealand Pharma A/S, a biotechnology company specializing in peptide-based medicines, announced its participation in the upcoming Cantor Global Healthcare Conference. The event is scheduled for September 18, 2024, where Chief Medical Officer David Kendall, MD, will engage in a fireside chat. This session is set to begin at 9:10 a.m. ET (3:10 p.m. CET) and will be accessible via a live audio webcast. The webcast can be found on the company's website, ensuring that interested parties can follow the discussion in real-time. The participation of Zealand Pharma at this prominent healthcare conference highlights the company's commitment to sharing insights into its innovative research and development efforts. The fireside chat format allows for an interactive discussion, providing an opportunity for attendees to gain deeper understanding of the company's strategic direction and advancements in peptide-based therapies. Following the live event, a recording of the webcast will be archived on the company's website, allowing stakeholders and interested individuals to access the information at their convenience. This approach not only enhances transparency but also fosters engagement with investors and the broader healthcare community. Overall, Zealand Pharma's involvement in the Cantor Global Healthcare Conference underscores its proactive stance in the biotechnology sector, aiming to showcase its developments and connect with investors and industry peers. The event serves as a platform for the company to articulate its vision and progress in the field of innovative medicines.